EUVIMEDEUVIMED entdecken
Editorial

Who Gets the Most Benefit From the Marshall Plan?

Michael Fletcher, Jason G Andrade

JACC: Clinical Electrophysiology · 2026-09

DOI: 10.1016/j.jacep.2026.08.012 ↗

Kurz gefasst

Editorial in der Zeitschrift JACC: Clinical Electrophysiology, 2026-09. Verfasst von Michael Fletcher und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiovascular Innovation, Vancouver, Canada; Dilawri Cardiovascular Institute, Vancouver General Hospital, Vancouver, Canada. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ethanol infusionpersistent atrial fibrillationvein of Marshall

Autor:innen und Institutionen

  • Center for Cardiovascular Innovation, Vancouver, Canada; Dilawri Cardiovascular Institute, Vancouver General Hospital, Vancouver, Canada.
  • Center for Cardiovascular Innovation, Vancouver, Canada; Dilawri Cardiovascular Institute, Vancouver General Hospital, Vancouver, Canada; Department of Medicine, Montreal Heart Institute, Université de Montréal, Montréa…

Zitieren

APA

Fletcher, M., & Andrade, J. G. (2026). Who Gets the Most Benefit From the Marshall Plan?. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2026.08.012

Vancouver

Fletcher M, Andrade JG. Who Gets the Most Benefit From the Marshall Plan?. JACC: Clinical Electrophysiology. 2026. doi:10.1016/j.jacep.2026.08.012

BibTeX
@article{Fletcher2026,
  author = {Fletcher, Michael and Andrade, Jason G},
  title = {Who Gets the Most Benefit From the Marshall Plan?},
  journal = {JACC: Clinical Electrophysiology},
  year = {2026},
  doi = {10.1016/j.jacep.2026.08.012}
}
Kostenlos starten →